SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
First Western Ship Transits Strait of Hormuz Since Iran War Began 
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom 
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO 
UPS and Teamsters Reach Agreement to Limit Driver Severance Program 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
Britain Courts Anthropic Amid US Defense Department Dispute 
CARLSBAD, Calif., July 07, 2017 -- SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycans, today announces a partnership with SkinSpirit, a recognized leader and expert in advanced aesthetic skin and body care treatments.
|
|||||
"We are thrilled to have SENTÉ products offered to patients in the impressive network of SkinSpirit clinics," said Laurent Combredet, President and Chief Executive Officer of SENTÉ. “SkinSpirit embodies everything SENTÉ thrives for, including exceptional patient outcomes, innovative skincare offerings and a strong emphasis on customer service.”
Since opening in 2003, SkinSpirit has since experienced significant growth and become one of the top destinations for aesthetic skin and body care in the country, with eight locations based in California and Washington.
"We spend a lot of time researching new skincare lines to find the best new products to make your skin look and feel great,” said Michael Dean Vistnes, MD, FACS, Founder and Medical Director of SkinSpirit. “SENTÉ fills the void in current skincare offerings by taking advantage of the latest science-backed evidence supporting the many incredible benefits of heparan sulfate."
About SENTÉ:
SENTÉ is a privately held specialty aesthetics company leveraging its expertise and foundation in biotechnology to deliver novel, science-based skin care products. SENTÉ is a recognized leader in the development of innovative and targeted skincare products based on glycosaminoglycans. Founded in 2007 and based in San Diego, California, further information may be found at sentelabs.com. SENTÉ products are available through its exclusive network of physicians and medically supervised spas.
About SkinSpirit
SkinSpirit is recognized as a leader and expert in the most effective skincare treatments for the face and body. The expert SkinSpirit team is led by Dr. Michael Dean Vistnes and Dr. Richard Baxter, who provide ongoing training in the newest techniques, ensuring the best care and results. Contact any one of our eight locations in the San Francisco Bay Area and Seattle Area to learn more or make an appointment. More information can be found at skinspirit.com.
Media Contact: Creative Media Marketing Danielle Hale [email protected] p: 212.979.8884 ext. 213
